NTHI NeOnc Technologies Holdings, Inc.
Company Analysis
Latest News
🟢 NeOnc Technologies Holdings is trading 6.4% up today amid a broader biotech rally
NeOnc Technologies Holdings is trading at $3.48 (up 6.4%), rebounding from recent volatility and declines following its at-the-market equity offering...
🔴 NeOnc Technologies Holdings, Inc. is trading 5.20% down
NTHI is trading at $3.28, down 5.20%.
🟢 NeOnc Technologies Holdings is trading 11.1% up
NeOnc Technologies Holdings is trading at $3.61, up 11.1% from a comparison close of $3.25 during after-hours. This is a price-action follow-up, so a separate...
🔴 NeOnc Technologies Holdings is trading 11.0% down
NeOnc Technologies Holdings is trading at $3.15, down 11.0% from a comparison close of $3.54 during regular trading. This is a price-action follow-up, so a...
🔴 NeOnc Technologies Holdings falls 6.2% amid dilution concerns, outweighing recent positive FDA feedback
NeOnc Technologies Holdings is trading at $3.32 (6.2% down) today as investors weigh ongoing dilution risks and the company’s cash needs following recent...
NTHI Bounces 8.8% After Dilution Selloff, but Can a Cash-Starved Brain Cancer Biotech Survive Its Own Fundraising?
Shares shifted as NeOnc Technologies Holdings (NTHI) climbed 8.8% to $4.00 on July 15, snapping a five-session slide that saw the stock fall from $4.49 to...
🟢 NeOnc Technologies Holdings Surges 8.8% on Positive FDA Feedback for NEO212
NeOnc Technologies Holdings is trading at $4.00 (8.8% up) today following positive regulatory news. The company announced receipt of written feedback from the...
🟢 NeOnc Technologies Holdings is trading 11.1% up
NeOnc Technologies Holdings is trading at $4.09, up 11.1% from a comparison close of $3.68 during pre-market. This is a price-action follow-up, so a separate...
🟢 NeOnc Technologies Holdings is trading 6% up today in a technical rebound after heavy selling
NeOnc Technologies Holdings is trading 6% up at $3.90 in pre-market, partially rebounding from its sharp July 14, 2026, drop to $3.68. • The upward move is...
🟢 NeOnc Technologies Holdings is trading 7.1% up today as it rebounds from a sharp regular-session decline
NeOnc Technologies Holdings is trading at $3.94 (7.1% up) in after-hours trading, rebounding from a sharp regular-session decline despite a lack of fresh...
🔴 NeOnc Technologies Holdings is trading 10.0% down
NeOnc Technologies Holdings is trading at $3.89, down 10.0% from a comparison close of $4.32 during regular trading. This is a price-action follow-up, so a...
🟢 NTHI makes sharp 11.4% jump
NTHI is trading at $5.00, up 11.4% versus the comparison close of $4.49 during after-hours. This is a price-movement alert; no separate company-specific...
🟢 NTHI is trading 5.1% up today with no clear catalyst identified yet
NTHI is trading 5.1% up at $4.72 in after-hours sessions, despite a lack of fresh earnings, SEC filings, or major news reports linked to NeOnc Technologies...
🔴 NTHI is trading 5.1% down today amid broader market softness
NTHI is trading at $4.30 (-5.08%) today, moving lower despite a lack of clear company-specific catalysts in current coverage. • The decline appears consistent...
🟢 NTHI is trading 5.1% up today as investors weigh UAE IND approval against share issuance concerns
NTHI is trading 5.1% up at $4.74 as investors reassess the impact of a potential $75 million share issuance against positive regulatory developments for its...
🔴 NTHI is trading 5.5% down today as a $75 million share issuance outweighs UAE IND approval
NTHI is trading 5.5% down at $4.45 as a potential $75 million share issuance creates a financing overhang, overshadowing positive regulatory news. • The...
🔴 NTHI is trading 5.1% down today on $75M financing overhang despite UAE IND authorization
NTHI is trading 5.1% down at $4.63 as a potential $75 million share issuance weighs on the stock, offsetting positive regulatory news from the Middle East. •...
NTHI Receives UAE IND Approval for Brain Cancer Candidate NEO100, Expanding Global Trials
NeOnc Technologies Holdings announced it has received Investigational New Drug (IND) status from the Department of Health – Abu Dhabi (DOH) for its lead...
🔴 NTHI is trading 5.9% down today on profit-taking after UAE regulatory approval spike
NTHI is trading 5.9% down today at $4.81 as investors take profits following a sharp rally driven by regulatory milestones in the UAE. • The stock recently...
🟢 NTHI is trading 5.03% up today after securing UAE IND approval for NEO100
• NeOnc Technologies Holdings, Inc. (NTHI) announced on June 23, 2026, that the Abu Dhabi health authority granted IND approval for NEO100 for multiple adult...